XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

Fair Value of Financial Instruments | 3 Months Ended
--- | ---
Mar. 31, 2025
Fair Value of Financial Instruments |
Fair Value of Financial Instruments | 10. Fair Value of Financial Instruments The Company carries certain financial assets and financial liabilities at fair value in accordance with GAAP which defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP permits entities to choose to measure many financial instruments and certain other items at fair value. The Company did not purchase or sell any financial assets or liabilities carried under the fair value option during the three months ended March 31, 2025 and 2024. The following table presents the financial assets and financial liabilities reported at fair value under the fair value option, and the changes in fair value included in the Consolidated Statement of Operations – Net (loss) gain from fair value adjustments, at or for the periods ended as indicated: ​ ​ ​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Changes in Fair Values For Items Measured at Fair Value
​ | ​ | Fair Value | ​ | Fair Value | ​ | Pursuant to Election of the Fair Value Option
​ |  | Measurements at |  | Measurements at | ​ | For the three months ended March 31,
Description |  | March 31, 2025 |  | December 31, 2024 |  | 2025 |  | 2024
(In thousands) |  | ​ |  |  | ​ |  | ​ | ​ |  |  | ​ |
Mortgage-backed securities | ​ | $ | 231 | ​ | $ | 237 | ​ | $ | — | ​ | $ | —
Other securities | ​ |  | 13,634 | ​ |  | 13,355 | ​ |  | 188 | ​ |  | (100)
Borrowed funds | ​ |  | 49,103 | ​ |  | 48,795 | ​ |  | (340) | ​ |  | (734)
Net gain (loss) from fair value adjustments | ​ | ​ | ​ | ​ | ​ | ​ | ​ | $ | (152) | ​ | $ | (834)
​ ​ Included in the fair value of the financial assets and financial liabilities selected for the fair value option is the accrued interest receivable or payable for the related instrument. The Company reports as interest income or interest expense in the Consolidated Statement of Operations, the interest receivable or payable on the financial instruments selected for the fair value option at their respective contractual rates. The borrowed funds had a contractual principal amount of $61.9 million at both March 31, 2025 and December 31, 2024. The fair value of borrowed funds includes accrued interest payable of $0.4 million at both March 31, 2025 and December 31, 2024. The Company generally holds its interest-earning assets to maturity and settles its liabilities at maturity. However, fair value estimates are made at a specific point in time and are based on relevant market information. These estimates do not reflect any premium or discount that could result from offering for sale at one time the Company’s entire holdings of a particular instrument. Accordingly, as assumptions change, such as interest rates and prepayments, fair value estimates change, and these amounts may not necessarily be realized in an immediate sale. Disclosure of fair value does not require fair value information for items that do not meet the definition of a financial instrument or certain other financial instruments specifically excluded from its requirements. These items include core deposit intangibles and other customer relationships, premises and equipment, leases, income taxes and equity. Further, fair value disclosure does not attempt to value future income or business. These items may be material and accordingly, the fair value information presented does not purport to represent, nor should it be construed to represent, the underlying “market” or franchise value of the Company. A description of the methods and significant assumptions utilized in estimating the fair value of the Company’s financial assets and liabilities that are carried at fair value on a recurring basis are as follows: Level 1 – when quoted market prices are available in an active market. At March 31, 2025 and December 31, 2024, Level 1 included one mutual fund. Level 2 – when quoted market prices are not available, fair value is estimated using quoted market prices for similar financial instruments and adjusted for differences between the quoted instrument and the instrument being valued. Fair value can also be estimated by using pricing models, or discounted cash flows. Pricing models primarily use market-based or independently sourced market parameters as inputs, including, but not limited to, yield curves, interest rates, equity or debt prices and credit spreads. In addition to observable market information, models also incorporate maturity and cash flow assumptions. At March 31, 2025 and December 31, 2024, Level 2 included mortgage-backed securities, CLOs, corporate debt, municipals, and interest rate swaps. Level 3 – when there is limited activity or less transparency around inputs to the valuation, financial instruments are classified as Level 3. At March 31, 2025 and December 31, 2024, Level 3 included trust preferred securities owned, and junior subordinated debentures issued by the Company, as well as municipal bonds. The methods described above may produce fair values that may not be indicative of net realizable value or reflective of future fair values. While the Company believes its valuation methods are appropriate and consistent with those of other market participants, the use of different methodologies, assumptions, and models to determine fair value of certain financial instruments could produce different estimates of fair value at the reporting date. The following table sets forth the Company’s assets and liabilities that are carried at fair value on a recurring basis, including those reported at fair value under the fair value option, and the level that was used to determine their fair value, at March 31, 2025 and December 31, 2024: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Quoted Prices | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | in Active Markets | ​ | Significant Other | ​ | Significant Other | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | for Identical Assets | ​ | Observable Inputs | ​ | Unobservable Inputs | ​ | Total carried at fair value
​ | ​ | (Level 1) | ​ | (Level 2) | ​ | (Level 3) | ​ | on a recurring basis
​ |  | 2025 |  | 2024 |  | 2025 |  | 2024 |  | 2025 |  | 2024 |  | 2025 |  | 2024
Assets: |  | (In thousands)
Securities available for sale: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Mortgage-backed securities | ​ | $ | — | ​ | $ | — | ​ | $ | 879,566 | ​ | $ | 911,636 | ​ | $ | — | ​ | $ | — | ​ | $ | 879,566 | ​ | $ | 911,636
Other securities | ​ |  | 12,160 | ​ |  | 11,890 | ​ |  | 538,944 | ​ |  | 554,914 | ​ |  | 19,474 | ​ |  | 19,465 | ​ |  | 570,578 | ​ |  | 586,269
Derivatives | ​ |  | — | ​ |  | — | ​ |  | 45,680 | ​ |  | 54,700 | ​ |  | — | ​ |  | — | ​ |  | 45,680 | ​ |  | 54,700
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total assets | ​ | $ | 12,160 | ​ | $ | 11,890 | ​ | $ | 1,464,190 | ​ | $ | 1,521,250 | ​ | $ | 19,474 | ​ | $ | 19,465 | ​ | $ | 1,495,824 | ​ | $ | 1,552,605
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Borrowings | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | 49,103 | ​ | $ | 48,795 | ​ | $ | 49,103 | ​ | $ | 48,795
Derivatives | ​ |  | — | ​ |  | — | ​ |  | 25,219 | ​ |  | 20,396 | ​ |  | — | ​ |  | — | ​ |  | 25,219 | ​ |  | 20,396
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total liabilities | ​ | $ | — | ​ | $ | — | ​ | $ | 25,219 | ​ | $ | 20,396 | ​ | $ | 49,103 | ​ | $ | 48,795 | ​ | $ | 74,322 | ​ | $ | 69,191
​ ​ The following table sets forth the Company’s assets and liabilities that are carried at fair value on a recurring basis, classified within Level 3 of the valuation hierarchy for the periods indicated: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the three months ended
​ | ​ | March 31, 2025 | ​ | March 31, 2024
​ | ​ | ​ | ​ | Trust preferred | ​ | Junior subordinated | ​ | Trust preferred | ​ | Junior subordinated
​ |  | Municipals |  | securities |  | debentures |  | securities |  | debentures
(In thousands) | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Beginning balance | ​ | $ | 18,000 | ​ | $ | 1,465 | ​ | $ | 48,795 | ​ | $ | 1,437 | ​ | $ | 47,850
Net gain (loss) from fair value adjustment of financial assets (1) | ​ |  | — | ​ |  | 10 | ​ |  | — | ​ |  | 23 | ​ |  | —
Net (gain) loss from fair value adjustment of financial liabilities (1) | ​ |  | — | ​ |  | — | ​ |  | 340 | ​ |  | — | ​ |  | 735
Increase (decrease) in accrued interest | ​ |  | — | ​ |  | (1) | ​ |  | (28) | ​ |  | — | ​ |  | (8)
Change in unrealized (gains) losses included in other comprehensive loss | ​ |  | — | ​ |  | — | ​ |  | (4) | ​ |  | — | ​ |  | 45
Ending balance | ​ | $ | 18,000 | ​ | $ | 1,474 | ​ | $ | 49,103 | ​ | $ | 1,460 | ​ | $ | 48,622
Changes in unrealized gains (losses) held at period end | ​ | $ | — | ​ | $ | — | ​ | $ | 2,287 | ​ | $ | — | ​ | $ | 2,379
(1) Presented in the Consolidated Statements of Operations under net (loss) gain from fair value adjustments. ​ ​ The following tables present the quantitative information about recurring Level 3 fair value of financial instruments and the fair value measurements at the periods indicated: ​ ​ ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, 2025
​ | ​ | ​ | ​ | ​ | Valuation | ​ | Input | ​ | ​ | ​ | Weighted
​ |  | Fair Value | ​ | Technique | ​ | Unobservable | ​ | Range | ​ | Average
​ | ​ | (Dollars in thousands)
Assets: | ​ |  |  |  |  |  |  |  |  |  |
Municipals | ​ | $ | 18,000 |  | Sales approach |  | Reduction for planned expedited disposal |  | n/a | ​ | n/a
Trust preferred securities | ​ | ​ | 1,474 |  | Discounted cash flows |  | Spread over 3-month SOFR |  | 4.2 | % | n/a
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities: | ​ |  |  |  |  |  |  |  |  | ​ |
Junior subordinated debentures | ​ | $ | 49,103 |  | Discounted cash flows |  | Spread over 3-month SOFR |  | 4.2 | % | n/a
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | December 31, 2024
​ | ​ | ​ | ​ | ​ | Valuation | ​ | Input | ​ | ​ | ​ | Weighted
​ |  | Fair Value | ​ | Technique | ​ | Unobservable | ​ | Range | ​ | Average
​ | ​ | (Dollars in thousands)
Assets: | ​ |  |  |  |  |  |  |  |  |  |
Municipals | ​ | $ | 18,000 |  | Sales approach |  | Reduction for planned expedited disposal |  | n/a | ​ | n/a
Trust preferred securities | ​ | ​ | 1,465 |  | Discounted cash flows |  | Spread over 3-month SOFR |  | 4.3 | % | n/a
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities: | ​ |  |  |  |  |  |  |  |  | ​ |
Junior subordinated debentures | ​ | $ | 48,795 |  | Discounted cash flows |  | Spread over 3-month SOFR |  | 4.3 | % | n/a
​ ​ The significant unobservable inputs used in the fair value measurement of the Company’s trust preferred securities and junior subordinated debentures valued under Level 3 at March 31, 2025 and December 31, 2024, are the effective yields used in the cash flow models. Significant increases or decreases in the effective yield in isolation would result in a significantly lower or higher fair value measurement. ​ ​ ​ The following table sets forth the Company’s assets and liabilities that are carried at fair value on a non-recurring basis and the level that was used to determine their fair value at March 31, 2025 and December 31, 2024: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Quoted Prices |  | ​ | ​ | ​ | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​ |  | ​ | ​
​ | ​ | in Active Markets | ​ | Significant Other | ​ | Significant Other | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | for Identical Assets | ​ | Observable Inputs | ​ | Unobservable Inputs | ​ | Total carried at fair value
​ | ​ | (Level 1) | ​ | (Level 2) | ​ | (Level 3) | ​ | on a non-recurring basis
​ |  | 2025 |  | 2024 |  | 2025 |  | 2024 |  | 2025 |  | 2024 |  | 2025 |  | 2024
​ |  | (In thousands)
Assets: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Impaired loans | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | 30,470 | ​ | $ | 16,784 | ​ | $ | 30,470 | ​ | $ | 16,784
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total assets | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | — | ​ | $ | 30,470 | ​ | $ | 16,784 | ​ | $ | 30,470 | ​ | $ | 16,784
​ ​ The following tables present the qualitative information about non-recurring Level 3 fair value of financial instruments and the fair value measurements at the periods indicated: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | At March 31, 2025 |
​ |  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average |
​ | ​ | (Dollars in thousands) |
Assets: |  | ​ |  |  |  |  |  |  |  |  |  | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Impaired loans |  | $ | 3,924 | ​ | Income approach | ​ | Capitalization rate | ​ | 4.8% to 6.5 | % | 5.90 | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Impaired loans |  | $ | 3,505 | ​ | Sales approach | ​ | Adjustment to sales comparison value | ​ | - | % | - | %
​ |  | ​ | ​ | ​ | ​ | ​ | Reduction for planned expedited disposal | ​ | 15.0 | % | 15.0 | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Impaired loans |  | $ | 1,647 | ​ | Discounted Cashflow | ​ | Discount Rate | ​ | 9.3 | % | 9.3 | %
​ |  | ​ | ​ | ​ | ​ | ​ | Probability of Default | ​ | 25.0 | % | 25.0 | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Impaired loans |  | $ | 21,394 | ​ | Blended income and sales approach | ​ | Adjustment to sales comparison value | ​ | -25.0% to 10.0 | % | (7.5) | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | Capitalization rate | ​ | 5.5 | % | 5.5 | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | Reduction for planned expedited disposal | ​ | 15.0 | % | 15.0 | %
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | At December 31, 2024 |
​ |  | Fair Value |  | Valuation Technique |  | Unobservable Input |  | Range |  | Weighted Average |
​ | ​ | (Dollars in thousands) |
Assets: |  | ​ |  |  |  |  |  |  |  |  |  | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Impaired loans |  | $ | 4,121 | ​ | Sales approach | ​ | Adjustment to sales comparison value | ​ | - | % | - | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | Reduction for planned expedited disposal | ​ | 15.0 | % | 15.0 | %
​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Impaired loans |  | $ | 2,453 | ​ | Discounted Cashflow | ​ | Discount Rate | ​ | 9.3% to 10.0 | % | 9.5 | %
​ |  | ​ | ​ | ​ | ​ | ​ | Probability of Default | ​ | 25.0% to 50.0 | % | 33.2 | %
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Impaired loans |  | $ | 10,210 | ​ | Income approach | ​ | Capitalization rate | ​ | 4.8% to 6.5 | % | 5.7 | %
​ The weighted average for unobservable inputs for collateral-dependent loans is based on the relative fair value of the loans. The Company did not have any liabilities that were carried at fair value on a non-recurring basis at March 31, 2025 and December 31, 2024. ​ The methods and assumptions used to estimate fair value at March 31, 2025 and December 31, 2024 are as follows: Securities: The fair values of securities are contained in Note 4 (“Securities”) of the Notes to Consolidated Financial Statements. Fair value is based upon quoted market prices, where available. If a quoted market price is not available, fair value is estimated using quoted market prices for similar securities and adjusted for differences between the quoted instrument and the instrument being valued. When there is limited activity or less transparency around inputs to the valuation, securities are valued using discounted cash flows. Impaired Loans: For impaired loans, fair value is generally estimated by discounting management’s estimate of future cash flows with a discount rate commensurate with the risk associated with such assets or, for collateral dependent loans, 85% of the appraised or internally estimated value of the property. See Note 5 (“Loans”) of the Notes to the Consolidated Financial Statements. Junior Subordinated Debentures: The fair value of the junior subordinated debentures was developed using a credit spread based on stated spreads for recently issued subordinated debt instruments for issuers of similar asset size and credit quality of the Company and with similar durations adjusting for differences in the junior subordinated debt’s credit rating, liquidity, and time to maturity. The unrealized net gain/loss attributable to changes in our own credit risk was determined by adjusting the fair value as determined in the proceeding sentence by the average rate of default on debt instruments with a similar debt rating as our junior subordinated debentures, with the difference from the original calculation and this calculation resulting in the instrument-specific unrealized gain/loss. Derivatives: The fair value of interest rate swaps is based upon broker quotes. The following tables set forth the carrying amounts and estimated fair values of selected financial instruments based on the assumptions described above used by the Company in estimating fair value at the periods indicated: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | March 31, 2025
​ | ​ | Carrying | ​ | Fair | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Amount |  | Value |  | Level 1 |  | Level 2 |  | Level 3
​ |  | (In thousands)
Assets: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and due from banks | ​ | $ | 271,912 | ​ | $ | 271,912 | ​ | $ | 271,912 | ​ | $ | — | ​ | $ | —
Securities held-to-maturity | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Mortgage-backed securities | ​ |  | 7,831 | ​ |  | 7,087 | ​ |  | — | ​ |  | 7,087 | ​ |  | —
Other securities | ​ |  | 43,319 | ​ |  | 37,583 | ​ |  | — | ​ |  | — | ​ |  | 37,583
Securities available for sale | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Mortgage-backed securities | ​ |  | 879,566 | ​ |  | 879,566 | ​ |  | — | ​ |  | 879,566 | ​ |  | —
Other securities | ​ |  | 570,578 | ​ |  | 570,578 | ​ |  | 12,160 | ​ |  | 538,944 | ​ |  | 19,474
Loans held for sale | ​ |  | 29,624 | ​ |  | 29,624 | ​ |  | — | ​ |  | — | ​ |  | 29,624
Loans held for investment, net of fees and costs | ​ |  | 6,741,835 | ​ |  | 6,496,787 | ​ |  | — | ​ |  | — | ​ |  | 6,496,787
FHLB-NY stock | ​ |  | 18,475 | ​ |  | 18,475 | ​ |  | — | ​ |  | 18,475 | ​ |  | —
Accrued interest receivable | ​ |  | 61,510 | ​ |  | 61,510 | ​ |  | — | ​ |  | 61,510 | ​ |  | —
Derivatives | ​ |  | 45,680 | ​ |  | 45,680 | ​ |  | — | ​ |  | 45,680 | ​ |  | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deposits | ​ | $ | 7,718,218 | ​ | $ | 7,702,976 | ​ | $ | 5,126,192 | ​ | $ | 2,576,784 | ​ | $ | —
Borrowed Funds | ​ |  | 421,542 | ​ |  | 396,718 | ​ |  | — | ​ |  | 347,615 | ​ |  | 49,103
Accrued interest payable | ​ |  | 12,609 | ​ |  | 12,609 | ​ |  | — | ​ |  | 12,609 | ​ |  | —
Derivatives | ​ |  | 25,219 | ​ |  | 25,219 | ​ |  | — | ​ |  | 25,219 | ​ |  | —
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | December 31, 2024
​ | ​ | Carrying | ​ | Fair | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Amount |  | Value |  | Level 1 |  | Level 2 |  | Level 3
​ | ​ | (In thousands)
Assets: |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Cash and due from banks | ​ | $ | 152,574 | ​ | $ | 152,574 | ​ | $ | 152,574 | ​ | $ | — | ​ | $ | —
Securities held-to-maturity | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Mortgage-backed securities | ​ |  | 7,836 | ​ |  | 6,903 | ​ |  | — | ​ |  | 6,903 | ​ |  | —
Other securities | ​ |  | 43,649 | ​ |  | 37,815 | ​ |  | — | ​ |  | — | ​ |  | 37,815
Securities available for sale | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Mortgage-backed securities | ​ |  | 911,636 | ​ |  | 911,636 | ​ |  | — | ​ |  | 911,636 | ​ |  | —
Other securities | ​ |  | 586,269 | ​ |  | 586,269 | ​ |  | 11,890 | ​ |  | 554,914 | ​ |  | 19,465
Loans held for sale | ​ |  | 70,098 | ​ |  | 70,098 | ​ |  | — | ​ |  | — | ​ |  | 70,098
Loans held for investment, net of fees and costs | ​ |  | 6,745,848 | ​ |  | 6,506,439 | ​ |  | — | ​ |  | — | ​ |  | 6,506,439
FHLB-NY stock | ​ |  | 38,096 | ​ |  | 38,096 | ​ |  | — | ​ |  | 38,096 | ​ |  | —
Accrued interest receivable | ​ |  | 62,036 | ​ |  | 62,036 | ​ |  | — | ​ |  | 62,036 | ​ |  | —
Derivatives | ​ |  | 54,700 | ​ |  | 54,700 | ​ |  | — | ​ |  | 54,700 | ​ |  | —
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Liabilities: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Deposits | ​ | $ | 7,178,933 | ​ | $ | 7,148,847 | ​ | $ | 4,528,769 | ​ | $ | 2,620,078 | ​ | $ | —
Borrowed Funds | ​ |  | 916,054 | ​ |  | 887,312 | ​ |  | — | ​ |  | 838,517 | ​ |  | 48,795
Accrued interest payable | ​ |  | 12,275 | ​ |  | 12,275 | ​ |  | — | ​ |  | 12,275 | ​ |  | —
Derivatives | ​ |  | 20,396 | ​ |  | 20,396 | ​ |  | — | ​ |  | 20,396 | ​ |  | —
​

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration